Since GEM/CIS-resistant CCA cell lines were found to have acquired vulnerability to SMAC mimetics, we examined the expressions of the SMAC mimetic target proteins XIAP, cIAP1, and cIAP2 in the resistant CCA cell lines via immunoblotting. This evidence concerns the gene BIRC3 and in situ carcinoma.